readthroughSign in
CompanyCRBUNasdaqBerkeley, CA

Caribou Biosciences, Inc.

Caribou Biosciences develops CRISPR genome-edited CAR-T cell therapies for hematologic malignancies.

10-QNov 12Latest SEC filing
Nov 5Latest story